Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
33
QDEL Quote, Financials, Valuation and Earnings
Last price:
$17.24
Seasonality move
:
5.16%
Day range:
$15.55 - $17.55
52-week range:
$14.45 - $38.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.45x
P/B ratio:
0.64x
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
-50.19%
Market cap:
$1.2B
Revenue:
$2.7B
EPS (TTM):
-$16.66
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
$682.8M | $0.47 | -1.6% | 480.41% | $39.17 |
|
ABT
Abbott Laboratories
|
$11B | $1.15 | 6.19% | 54.77% | $132.28 |
|
BSX
Boston Scientific Corp.
|
$5.2B | $0.79 | 11.18% | 75.33% | $100.81 |
|
ITGR
Integer Holdings Corp.
|
$426M | $1.19 | -2.33% | 88.24% | $93.25 |
|
PODD
Insulet Corp.
|
$729.9M | $1.20 | 28.28% | 138.1% | $351.43 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$240.6M | -$0.44 | 2.62% | -77.49% | $30.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
$17.25 | $39.17 | $1.2B | -- | $0.00 | 0% | 0.45x |
|
ABT
Abbott Laboratories
|
$102.87 | $132.28 | $179.6B | 27.81x | $0.63 | 2.32% | 4.08x |
|
BSX
Boston Scientific Corp.
|
$62.82 | $100.81 | $94.5B | 32.82x | $0.00 | 0% | 4.74x |
|
ITGR
Integer Holdings Corp.
|
$86.85 | $93.25 | $3B | 30.41x | $0.00 | 0% | 1.66x |
|
PODD
Insulet Corp.
|
$204.31 | $351.43 | $14.2B | 57.60x | $0.00 | 0% | 5.33x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$18.61 | $30.76 | $1.3B | -- | $0.00 | 0% | 1.22x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
59.61% | 2.805 | 146.07% | 0.74x |
|
ABT
Abbott Laboratories
|
21.33% | 0.736 | 6.98% | 1.05x |
|
BSX
Boston Scientific Corp.
|
33.07% | 1.671 | 8.45% | 0.94x |
|
ITGR
Integer Holdings Corp.
|
43% | -1.228 | 48.92% | 2.05x |
|
PODD
Insulet Corp.
|
39.8% | 2.432 | 5.01% | 1.82x |
|
TNDM
Tandem Diabetes Care, Inc.
|
74.33% | 1.046 | 29.94% | 1.92x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
$274.6M | -$37.5M | -21.29% | -44.45% | -5.19% | $86.6M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
ITGR
Integer Holdings Corp.
|
$106.1M | $51.1M | 3.47% | 6.11% | 10.86% | $27.9M |
|
PODD
Insulet Corp.
|
$570.3M | $146.3M | 9.17% | 17.89% | 18.67% | $33.9M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$167.5M | $8.3M | -32.45% | -121.88% | 2.86% | $3.1M |
QuidelOrtho Corp. vs. Competitors
-
Which has Higher Returns QDEL or ABT?
Abbott Laboratories has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 15.71%. QuidelOrtho Corp.'s return on equity of -44.45% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About QDEL or ABT?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 127.05%. On the other hand Abbott Laboratories has an analysts' consensus of $132.28 which suggests that it could grow by 28.59%. Given that QuidelOrtho Corp. has higher upside potential than Abbott Laboratories, analysts believe QuidelOrtho Corp. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 ABTAbbott Laboratories16 7 0 -
Is QDEL or ABT More Risky?
QuidelOrtho Corp. has a beta of 0.920, which suggesting that the stock is 7.97% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.787, suggesting its less volatile than the S&P 500 by 21.251%.
-
Which is a Better Dividend Stock QDEL or ABT?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.32% to investors and pays a quarterly dividend of $0.63 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios QDEL or ABT?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. QuidelOrtho Corp.'s net income of -$130.7M is lower than Abbott Laboratories's net income of $1.8B. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 27.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.45x versus 4.08x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.45x -- $723.3M -$130.7M ABTAbbott Laboratories4.08x 27.81x $11.5B $1.8B
-
Which has Higher Returns QDEL or BSX?
Boston Scientific Corp. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 12.68%. QuidelOrtho Corp.'s return on equity of -44.45% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About QDEL or BSX?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 127.05%. On the other hand Boston Scientific Corp. has an analysts' consensus of $100.81 which suggests that it could grow by 60.48%. Given that QuidelOrtho Corp. has higher upside potential than Boston Scientific Corp., analysts believe QuidelOrtho Corp. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 BSXBoston Scientific Corp.24 0 0 -
Is QDEL or BSX More Risky?
QuidelOrtho Corp. has a beta of 0.920, which suggesting that the stock is 7.97% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.926%.
-
Which is a Better Dividend Stock QDEL or BSX?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or BSX?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. QuidelOrtho Corp.'s net income of -$130.7M is lower than Boston Scientific Corp.'s net income of $670M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 32.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.45x versus 4.74x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.45x -- $723.3M -$130.7M BSXBoston Scientific Corp.4.74x 32.82x $5.3B $670M
-
Which has Higher Returns QDEL or ITGR?
Integer Holdings Corp. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 10.32%. QuidelOrtho Corp.'s return on equity of -44.45% beat Integer Holdings Corp.'s return on equity of 6.11%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B ITGRInteger Holdings Corp.22.53% $1.38 $3.1B -
What do Analysts Say About QDEL or ITGR?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 127.05%. On the other hand Integer Holdings Corp. has an analysts' consensus of $93.25 which suggests that it could grow by 7.37%. Given that QuidelOrtho Corp. has higher upside potential than Integer Holdings Corp., analysts believe QuidelOrtho Corp. is more attractive than Integer Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 ITGRInteger Holdings Corp.3 5 0 -
Is QDEL or ITGR More Risky?
QuidelOrtho Corp. has a beta of 0.920, which suggesting that the stock is 7.97% less volatile than S&P 500. In comparison Integer Holdings Corp. has a beta of 0.710, suggesting its less volatile than the S&P 500 by 28.956%.
-
Which is a Better Dividend Stock QDEL or ITGR?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Integer Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or ITGR?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are larger than Integer Holdings Corp. quarterly revenues of $470.9M. QuidelOrtho Corp.'s net income of -$130.7M is lower than Integer Holdings Corp.'s net income of $48.6M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Integer Holdings Corp.'s PE ratio is 30.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.45x versus 1.66x for Integer Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.45x -- $723.3M -$130.7M ITGRInteger Holdings Corp.1.66x 30.41x $470.9M $48.6M
-
Which has Higher Returns QDEL or PODD?
Insulet Corp. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 12.96%. QuidelOrtho Corp.'s return on equity of -44.45% beat Insulet Corp.'s return on equity of 17.89%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B PODDInsulet Corp.72.76% $1.44 $2.5B -
What do Analysts Say About QDEL or PODD?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 127.05%. On the other hand Insulet Corp. has an analysts' consensus of $351.43 which suggests that it could grow by 72.01%. Given that QuidelOrtho Corp. has higher upside potential than Insulet Corp., analysts believe QuidelOrtho Corp. is more attractive than Insulet Corp..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 PODDInsulet Corp.17 1 0 -
Is QDEL or PODD More Risky?
QuidelOrtho Corp. has a beta of 0.920, which suggesting that the stock is 7.97% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.012%.
-
Which is a Better Dividend Stock QDEL or PODD?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or PODD?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are smaller than Insulet Corp. quarterly revenues of $783.8M. QuidelOrtho Corp.'s net income of -$130.7M is lower than Insulet Corp.'s net income of $101.6M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Insulet Corp.'s PE ratio is 57.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.45x versus 5.33x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.45x -- $723.3M -$130.7M PODDInsulet Corp.5.33x 57.60x $783.8M $101.6M
-
Which has Higher Returns QDEL or TNDM?
Tandem Diabetes Care, Inc. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of -0.2%. QuidelOrtho Corp.'s return on equity of -44.45% beat Tandem Diabetes Care, Inc.'s return on equity of -121.88%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B TNDMTandem Diabetes Care, Inc.57.67% -$0.01 $604.5M -
What do Analysts Say About QDEL or TNDM?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 127.05%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $30.76 which suggests that it could grow by 65.3%. Given that QuidelOrtho Corp. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe QuidelOrtho Corp. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 TNDMTandem Diabetes Care, Inc.9 11 0 -
Is QDEL or TNDM More Risky?
QuidelOrtho Corp. has a beta of 0.920, which suggesting that the stock is 7.97% less volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.737, suggesting its more volatile than the S&P 500 by 73.689%.
-
Which is a Better Dividend Stock QDEL or TNDM?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or TNDM?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are larger than Tandem Diabetes Care, Inc. quarterly revenues of $290.4M. QuidelOrtho Corp.'s net income of -$130.7M is lower than Tandem Diabetes Care, Inc.'s net income of -$589K. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.45x versus 1.22x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.45x -- $723.3M -$130.7M TNDMTandem Diabetes Care, Inc.1.22x -- $290.4M -$589K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
